Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETR vs GSK✓SelectedUSD · GSKETR vs GSK performance historyLatest closeAs of-1.69%11/19
Stock and ETF performance explorer

ETR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+135.2%
GSK return
+53.5%
Excess return
+81.7%
Maximum drawdown
-15.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-1.6%-0.1%-1.5%
7D-4.6%-4.7%+0.1%-3.9%
30D+1.6%-4.7%+6.3%+2.2%
3M-1.0%-8.8%+7.7%+0.1%
6M-2.8%-4.6%+1.8%-2.3%
YTD+17.7%+1.0%+16.7%+17.4%
1Y+15.7%+6.9%+8.8%+14.6%
All+135.2%+53.5%+81.7%+107.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling